Clinical Trial

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

Study acronym: SWYFT
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the SPYRAL SWYFT sub-study is to evaluate whether renal denervation with the Symplicity Spyral system performed in the main and first order branch renal arteries yields a shorter procedure time and is as effective in reducing blood pressure than the procedural approach used in the SPYRAL HTN-ON MED and SPYRAL PIVOTAL - SPYRAL HTN-OFF MED clinical studies in an uncontrolled hypertensive population.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2025-08-04; most recent amendment 2026-06-29.
Status change: Not Yet Recruiting → Recruiting 2025-08-27
Trial Details
NCT Number NCT07115953
Lead Sponsor Medtronic Vascular
Conditions Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
Enrollment 130 participants
Start Date 2025-09-22
Primary Completion 2027-06-30 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-30